chr1-85464927-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000284031.13(DDAH1):āc.119T>Cā(p.Val40Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00013 in 1,549,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000079 ( 0 hom., cov: 33)
Exomes š: 0.00014 ( 0 hom. )
Consequence
DDAH1
ENST00000284031.13 missense
ENST00000284031.13 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 3.89
Genes affected
DDAH1 (HGNC:2715): (dimethylarginine dimethylaminohydrolase 1) This gene belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. The encoded enzyme plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10517892).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDAH1 | NM_012137.4 | c.119T>C | p.Val40Ala | missense_variant | 1/6 | ENST00000284031.13 | NP_036269.1 | |
DDAH1 | NM_001134445.2 | c.-7+31239T>C | intron_variant | NP_001127917.1 | ||||
DDAH1 | XM_005270707.3 | c.19-106080T>C | intron_variant | XP_005270764.1 | ||||
DDAH1 | XM_011541158.2 | c.-87+31239T>C | intron_variant | XP_011539460.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDAH1 | ENST00000284031.13 | c.119T>C | p.Val40Ala | missense_variant | 1/6 | 1 | NM_012137.4 | ENSP00000284031 | P1 | |
DDAH1 | ENST00000426972.8 | c.-7+31239T>C | intron_variant | 1 | ENSP00000411189 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152066Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
12
AN:
152066
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000514 AC: 8AN: 155664Hom.: 0 AF XY: 0.0000572 AC XY: 5AN XY: 87410
GnomAD3 exomes
AF:
AC:
8
AN:
155664
Hom.:
AF XY:
AC XY:
5
AN XY:
87410
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000136 AC: 190AN: 1397848Hom.: 0 Cov.: 33 AF XY: 0.000130 AC XY: 90AN XY: 693514
GnomAD4 exome
AF:
AC:
190
AN:
1397848
Hom.:
Cov.:
33
AF XY:
AC XY:
90
AN XY:
693514
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152066Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74278
GnomAD4 genome
AF:
AC:
12
AN:
152066
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74278
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2023 | The c.119T>C (p.V40A) alteration is located in exon 1 (coding exon 1) of the DDAH1 gene. This alteration results from a T to C substitution at nucleotide position 119, causing the valine (V) at amino acid position 40 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Uncertain
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
T
Polyphen
B
Vest4
MutPred
Gain of disorder (P = 0.0711);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at